In honor of cervical cancer awareness month, Lauren Bollinger, MD, a gynecologic oncologist with Minnesota Oncology, recently authored an article for Targeted Oncology on cervical cancer research and treatment.
Dr. Bollinger discusses how the increase in research in the field of cervical cancer is driving the progress of treatment.
“The cervical cancer landscape is dramatically changing for the better as new drug therapies, including antibody drug conjugates and immunotherapies, come into play vs traditional chemotherapy. Taking a closer look at what is driving all this excitement is worthwhile, as these developments will likely impact the standard of care for patients with cervical cancer for years to come.”
Read the article: Cervical Cancer Awareness Month: Dramatic Increase in Cervical Cancer Research is Driving Treatment Progress
Share
Categories
Tags
Recent Posts
Why Diversity in Cancer Clinical Trials is Important. Cancer is a disease that affects people from all walks of life, regardless of age, race, or ethnicity. However, when it comes to studying cancer and testing new treatments, not everyone is equally represented.
Who Can Participate in Clinical Trials for Cancer? Clinical trials are research studies that test new treatments or procedures to determine their safety and effectiveness. Understanding who can participate in these trials is crucial for patients and their families, as well as for healthcare providers who guide patients through their treatment options.
The Importance of Clinical Trials. Clinical trials are very important in medical research and help make healthcare better.